Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Estrogens; total

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 82672 refers to a laboratory test that quantifies the total amount of estrogens present in the blood. This test encompasses the measurement of three primary forms of estrogen: estradiol, estriol, and estrone. These hormones play crucial roles in various physiological processes, including the regulation of the menstrual cycle, reproductive health, and bone density. The test is performed by obtaining a blood sample through venipuncture, which is a standard procedure for collecting blood for laboratory analysis. The estrogens can be measured in either plasma or serum, providing flexibility in the testing process. Unlike the fractionated estrogen test (CPT® Code 82671), which measures estradiol and estrone separately and calculates the total estrogen, the total estrogen test (CPT® Code 82672) combines the measurements of all three estrogens and reports them as a single value. This comprehensive approach is particularly useful in diagnosing conditions related to estrogen production, such as ovarian tumors in females and elevated estrogen levels in males. Additionally, the total estrogen test can assist in determining ovulation timing, which is essential for couples trying to conceive.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The total estrogen test (CPT® Code 82672) is indicated for various clinical scenarios where the assessment of estrogen levels is necessary. The following conditions and situations warrant the performance of this test:

  • Diagnosis of Estrogen-Producing Ovarian Tumors - This test is utilized to identify ovarian tumors that produce estrogen in both pre-menarche and post-menopausal females.
  • Evaluation of Elevated Estrogen Levels in Males - The test helps assess abnormal estrogen levels in male patients, which may indicate underlying health issues.
  • Assessment of Ovulation Timing - The total estrogen measurement can be used to establish the timing of ovulation, aiding in fertility evaluations and planning for conception.
  • Monitoring Hormone Replacement Therapy - In post-menopausal women undergoing hormone replacement therapy, this test assists in monitoring estrogen levels to ensure appropriate treatment.
  • Evaluation of Disorders of Sex Steroid Metabolism - The test can help diagnose conditions related to abnormal metabolism of sex steroids, which may affect reproductive health.
  • Assessment of Bone Mineral Density - Estrogen levels are critical for bone health, and this test can be part of the evaluation process for bone mineral density.
  • Evaluation of Hypogonadism and Oligo-Amenorrhea - The test is useful in assessing conditions such as hypogonadism and irregular menstrual cycles in women.

2. Procedure

The procedure for performing the total estrogen test (CPT® Code 82672) involves several key steps to ensure accurate measurement of estrogen levels in the blood. The following outlines the procedural steps:

  • Step 1: Patient Preparation - Prior to the blood draw, the patient may be instructed to avoid certain medications or supplements that could affect estrogen levels. It is essential to gather a thorough medical history to understand any factors that may influence the test results.
  • Step 2: Venipuncture - A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to collect the necessary volume of blood for analysis. Proper aseptic technique is employed to minimize the risk of infection.
  • Step 3: Sample Handling - Once the blood sample is collected, it is processed according to laboratory protocols. The sample may be placed in a specific type of tube that preserves the integrity of the estrogens for accurate measurement.
  • Step 4: Laboratory Analysis - The laboratory utilizes established methods, such as chemiluminescent immunoassay or tandem mass spectrometry, to measure the total levels of estradiol, estriol, and estrone in the blood sample. The results are calculated and reported as a single value representing the total estrogens.
  • Step 5: Reporting Results - After analysis, the laboratory generates a report detailing the total estrogen levels. This report is then sent to the requesting healthcare provider for interpretation and further clinical decision-making.

3. Post-Procedure

After the total estrogen test (CPT® Code 82672) is completed, there are generally no specific post-procedure care requirements for the patient. However, it is advisable for patients to remain hydrated and to follow any additional instructions provided by their healthcare provider. The results of the test will typically be reviewed in conjunction with the patient's clinical history and other diagnostic findings to guide further management or treatment decisions. Patients may be advised to schedule a follow-up appointment to discuss the results and any necessary next steps based on the findings.

Short Descr ASSAY OF ESTROGEN
Medium Descr ASSAY OF ESTROGENS TOTAL
Long Descr Estrogens; total
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Q4 Service for ordering/referring physician qualifies as a service exemption
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GA Waiver of liability statement issued as required by payer policy, individual case
GW Service not related to the hospice patient's terminal condition
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GZ Item or service expected to be denied as not reasonable and necessary
KX Requirements specified in the medical policy have been met
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"